
|Articles|May 16, 2020
ASCRS 2020: Updates, improved injection technique from Eyepoint Pharmaceuticals
Author(s)Alex Delaney-Gesing
Advertisement
Ophthalmology Times' Sheryl Stevenson speaks with Eyepoint Pharmaceuticals' President/CEO Nancy Lurker and Chief Medical Officer Dario Paggiarino, MD, on the company's latest developments and research ahead of the ASCRS 2020 virtual meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
2
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
3
Thyroid eye disease specialists react to the FDA approval of veligrotug-vvze
4
From detection to decision-making: Navigating disease progression and treatment in geographic atrophy
5
























